Stem-Cell Research
Company reports progress in development of hESC-based therapies
Published in Blood Weekly, July 15th, 2004
In nine presentations at the annual meeting of the International Society for Stem Cell Research (ISSCR) in Boston, Massachusetts, Geron and its collaborators reported advancements in the differentiation of hESCs to therapeutic cell types, the engraftment of these differentiated cells in animal models, and the production of cells for eventual clinical testing.
Adding to the list of prospective therapeutic cells already produced from hESCs, Geron scientists demonstrated the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-07-15)
More Articles from Blood Weekly
- Creutzfeldt-Jakob Disease
Molecular diagnostic tools aim to identify healthy persons with prion disorders - Hepatitis C Virus Therapy
Epoetin alfa might minimize ribavirin-related blood disorders - Stem-Cell Research
Abundant progenitor cells in adventitia contribute to atherosclerosis - Stem-Cell Research
Dendritic cell implantation leads to repair of injured adult spinal cords - Stem-Cell Research
Transient beta-catenin signal activation in epidermis induces new hair follicles - Tissue Engineering
Allogenic fibroblasts do not survive transplantation in porcine wound model - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
